Comparison of adverse reactions of combination chemotherapy: lobaplatin versus oxaliplatin
Hongfeng Zhou, Hui-Xin Kang, Jianwen Deng(Peking University), Liangping Wu(Guangzhou University), Hongliang Ding(Science and Technology Department of Sichuan Province), Yuxin Zhang
Cited by 1
Related Papers
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
|Journal of Clinical Oncology|2019|410
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
|Journal of Clinical Oncology|2016|409
TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response
|PLoS Genetics|2019|296
Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression
|Nature Communications|2018|241
FUS Interacts with HSP60 to Promote Mitochondrial Damage
|PLoS Genetics|2015|195